Table 3.
Antiretroviral drug use in the control and intervention arms of HPTN 043 (intervention effect)*.
| Site | # with ARV test resultsa,b
|
# with ARV drugs detected (%)a,c
|
Effectd | Analytic weighte | ||
|---|---|---|---|---|---|---|
| Control | Intervention | Control | Intervention | |||
| Zimbabwe | 751 | 776 | 133 (17.7) | 192 (24.7) | 7.08 | 20.9 |
| Tanzania | 250 | 281 | 59 (23.6) | 55 (19.6) | −5.03 | 7.2 |
| KwaZulu-Natal | 1,777 | 1,834 | 572 (32.2) | 571 (31.1) | −0.90 | 49.8 |
| Soweto | 932 | 712 | 242 (26.0) | 175 (24.6) | −0.75 | 22.0 |
| All | 3,710 | 3,603 | 1,006 (27.1) | 993 (27.6) | 0.51 | 100.0 |
*
The table shows the number and percentage of individuals in the control and intervention arms of the HPTN 043 study who had at least one antiretroviral (ARV) drug detected.
a
Control: standard voluntary HIV counseling and testing; Intervention: community-based voluntary HIV counseling and testing.
b
Number of HIV-infected individuals with ARV test results.
c
Number of HIV-infected individuals with at least one ARV drug detected.
d
Weighted absolute difference in prevalence of ARV drug use between intervention and control communities.
e
Contribution of each site to the analysis (in %).